Teva Pharmaceutical Industries Limited
TEVA
Peringkat dalam Saham
#13240
Teva Pharmaceutical Industries Limited operates as a prominent global... Teva Pharmaceutical Industries Limited operates as a prominent global pharmaceutical firm, involved in the research, development, manufacturing, marketing, and distribution of generic, specialized, and biopharmaceutical products throughout North America, Europe, and other international regions. The company's diverse portfolio encompasses sterile preparations, hormonal therapies, high-potency drugs, and cytotoxic substances, supplied in a wide array of dosage forms such as tablets, capsules, injectable solutions, inhalants, oral liquids, transdermal patches, topical ointments, and creams. Furthermore, Teva develops, produces, and sells active pharmaceutical ingredients (APIs). A significant portion of its research and product development is concentrated on the central nervous system, pain management, respiratory illnesses, and oncology. Leading products for the central nervous system include Copaxone, utilized for relapsing multiple sclerosis; AJOVY, an option for migraine prevention; and AUSTEDO, prescribed for tardive dyskinesia and chorea linked to Huntington's disease. Within the respiratory domain, addressing asthma and chronic obstructive pulmonary disease, Teva offers products like ProAir, QVAR, various Digihaler and RespiClick formulations, along with BRALTUS and CINQAIR/CINQAERO. Their oncology division features treatments such as Bendeka, Treanda, Granix, Trisenox, Lonquex, and Tevagrastim/Ratiograstim. The company also collaborates with MedinCell on the creation and commercialization of multiple extended-release injectable products, including a risperidone suspension designed for individuals with schizophrenia. Teva Pharmaceutical Industries Limited was founded in 1901 and is headquartered in Tel Aviv-Yafo, Israel.
Harga Saham
$41.51
Terakhir disinkronkan: 2026-10-16
Kapitalisasi Pasar
$483.77M
Perubahan (1 hari)
-0.85%
Perubahan (1 tahun)
107.47%
Negara
IL
Perdagangan Teva Pharmaceutical Industries Limited (TEVA)
Kategori
Healthcare
Kapitalisasi pasar dari Teva Pharmaceutical Industries Limited(TEVA)
Kapitalisasi Pasar: $483.77M
Per October 2026, Teva Pharmaceutical Industries Limited memiliki kapitalisasi pasar sebesar $483.77M. Ini menjadikan Teva Pharmaceutical Industries Limited sebagai perusahaan 13240th paling bernilai di dunia menurut data kami. Kapitalisasi pasar adalah nilai total saham beredar dari perusahaan publik dan biasanya digunakan untuk mengukur seberapa besar nilai sebuah perusahaan.
Riwayat kapitalisasi pasar Teva Pharmaceutical Industries Limited dari 2010 hingga 2026
TEVA dibandingkan dengan 5 teratas stocks paling populer
